Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01075412 · ClinicalTrials.gov registry record · Phase 2
FLT PET Imaging for Cervical Cancer
A Phase 2 study, sponsored by University of Iowa.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT01075412 is a Phase 2 study that was terminated before completion, run by University of Iowa. The registered enrollment target is 6 participants.
The verdict
NCT01075412, a Phase 2 study, was terminated before completion, sponsored by University of Iowa.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
Our primary hypothesis is that \[18F\]FLT PET can identify active bone marrow in addition to metabolically active tumor. This trial will use FLT-PET imaging to define areas of active bone marrow in the pelvis. The radiation plan is then designed to spare that area, in hopes of keeping the bone marrow active during therapy. Bone marrow and tumor activity will be monitored using a sequence of FLT PET scans during the course of chemotherapy and radiation therapy.
Interventions
- DRUG [F18]Fluorothymidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-04-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01075412
The ClinicalTrials.gov registry entry for NCT01075412 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [F18]Fluorothymidine is the first listed.
NCT01075412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01075412 about?
NCT01075412 is a clinical study titled "FLT PET Imaging for Cervical Cancer". Our primary hypothesis is that \[18F\]FLT PET can identify active bone marrow in addition to metabolically active tumor. This trial will use FLT-PET imaging to define areas of active bone marrow in the pelvis. The radiation plan is then designed to spare that area, in hopes of keeping the bone marr...
What is the current status of trial NCT01075412?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2009-09. Estimated completion is 2016-04-11.
What interventions are being tested in trial NCT01075412?
The interventions under investigation include: [F18]Fluorothymidine (DRUG).
Who is sponsoring clinical trial NCT01075412?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.